Ajanta Pharma Statistics
Total Valuation
Ajanta Pharma has a market cap or net worth of INR 336.60 billion. The enterprise value is 330.97 billion.
Market Cap | 336.60B |
Enterprise Value | 330.97B |
Important Dates
The last earnings date was Sunday, July 27, 2025.
Earnings Date | Jul 27, 2025 |
Ex-Dividend Date | Nov 6, 2024 |
Share Statistics
Ajanta Pharma has 124.89 million shares outstanding. The number of shares has decreased by -0.82% in one year.
Current Share Class | 124.89M |
Shares Outstanding | 124.89M |
Shares Change (YoY) | -0.82% |
Shares Change (QoQ) | -0.13% |
Owned by Insiders (%) | 42.34% |
Owned by Institutions (%) | 20.84% |
Float | 41.84M |
Valuation Ratios
The trailing PE ratio is 36.21 and the forward PE ratio is 31.42. Ajanta Pharma's PEG ratio is 2.86.
PE Ratio | 36.21 |
Forward PE | 31.42 |
PS Ratio | 7.00 |
PB Ratio | 8.88 |
P/TBV Ratio | 8.99 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | 2.86 |
Enterprise Valuation
EV / Earnings | 35.59 |
EV / Sales | 6.89 |
EV / EBITDA | 25.37 |
EV / EBIT | 28.35 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.01 |
Debt / EBITDA | 0.04 |
Debt / FCF | n/a |
Interest Coverage | 46.21 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 19.60% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 4.99M |
Profits Per Employee | 965,891 |
Employee Count | 9,628 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Ajanta Pharma has paid 2.68 billion in taxes.
Income Tax | 2.68B |
Effective Tax Rate | 22.38% |
Stock Price Statistics
The stock price has increased by +0.00% in the last 52 weeks. The beta is 0.18, so Ajanta Pharma's price volatility has been lower than the market average.
Beta (5Y) | 0.18 |
52-Week Price Change | +0.00% |
50-Day Moving Average | 2,639.29 |
200-Day Moving Average | 2,737.64 |
Relative Strength Index (RSI) | 48.88 |
Average Volume (20 Days) | 158,337 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ajanta Pharma had revenue of INR 48.06 billion and earned 9.30 billion in profits. Earnings per share was 74.42.
Revenue | 48.06B |
Gross Profit | 36.55B |
Operating Income | 11.67B |
Pretax Income | 11.98B |
Net Income | 9.30B |
EBITDA | 12.92B |
EBIT | 11.67B |
Earnings Per Share (EPS) | 74.42 |
Balance Sheet
The company has 6.14 billion in cash and 509.20 million in debt, giving a net cash position of 5.63 billion or 45.07 per share.
Cash & Cash Equivalents | 6.14B |
Total Debt | 509.20M |
Net Cash | 5.63B |
Net Cash Per Share | 45.07 |
Equity (Book Value) | 37.90B |
Book Value Per Share | 301.59 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 76.05%, with operating and profit margins of 24.29% and 19.35%.
Gross Margin | 76.05% |
Operating Margin | 24.29% |
Pretax Margin | 24.93% |
Profit Margin | 19.35% |
EBITDA Margin | 26.89% |
EBIT Margin | 24.29% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 28.00, which amounts to a dividend yield of 1.02%.
Dividend Per Share | 28.00 |
Dividend Yield | 1.02% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 3 |
Payout Ratio | n/a |
Buyback Yield | 0.82% |
Shareholder Yield | 1.83% |
Earnings Yield | 2.76% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on June 22, 2022. It was a forward split with a ratio of 1.5.
Last Split Date | Jun 22, 2022 |
Split Type | Forward |
Split Ratio | 1.5 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |